The FALCON trial: Impact of 18F-fluciclovine PET/CT on clinical management choices for men with biochemically recurrent prostate cancer.
暂无分享，去创建一个
N. V. As | F. Gleeson | A. Afaq | G. Cook | A. Scarsbrook | P. Hoskin | D. Bottomley | H. Payne | S. Chua | V. Warbey | J. Bomanji | E. Teoh | L. Wilson | A. Chau | Matthew P. Miller | A. Chambers | D. Stevens | P. Ward